SuppreMol GmbH-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:SuppreMol GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013265
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
SuppreMol GmbH (SuppreMol), a subsidiary of Baxalta Inc, is a biopharmaceutical company that develops therapeutics in the areas of autoimmune, chronic inflammatory diseases, and allergies. The company’s lead drug candidate is extensively profiled in in-vitro, ex-vivo and in-vivo experiments. Its antibody is used to restrict cellular activation signals mediated by the B cell receptor. SuppreMol also works on anti-Fc?RIIb antibodies, which can be useful for the treatment of autoimmune diseases(and allergic reactions . The company conducts research and development to develop new drugs. SuppreMol is headquartered in Munich, Germany.

SuppreMol GmbH – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
SuppreMol GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
SuppreMol GmbH, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
SuppreMol GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
SuppreMol GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
SuppreMol GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
SuppreMol GmbH, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Suppremol Raises US$20.6 Million In Series D Financing 10
Licensing Agreements 11
SuppreMol Exercises Option For Licensing Agreement With Bayerische For RA Antibody 11
Acquisition 13
Baxter International Acquires SuppreMol for USD225 Million 13
SuppreMol GmbH – Key Competitors 14
SuppreMol GmbH – Key Employees 15
SuppreMol GmbH – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
SuppreMol GmbH, Pharmaceuticals & Healthcare, Key Facts 2
SuppreMol GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
SuppreMol GmbH, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
SuppreMol GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
SuppreMol GmbH, Deals By Therapy Area, 2011 to YTD 2017 8
SuppreMol GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Suppremol Raises US$20.6 Million In Series D Financing 10
SuppreMol Exercises Option For Licensing Agreement With Bayerische For RA Antibody 11
Baxter International Acquires SuppreMol for USD225 Million 13
SuppreMol GmbH, Key Competitors 14
SuppreMol GmbH, Key Employees 15

★海外企業調査レポート[SuppreMol GmbH-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Shimano Inc (7309):企業の財務・戦略的SWOT分析
    Shimano Inc (7309) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Kokuyo Camlin Ltd (KOKUYOCMLN):企業の財務・戦略的SWOT分析
    Kokuyo Camlin Ltd (KOKUYOCMLN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Tecpetrol SA:企業の戦略的SWOT分析
    Tecpetrol SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • East Energy Resources Limited:企業の戦略・SWOT・財務情報
    East Energy Resources Limited - Strategy, SWOT and Corporate Finance Report Summary East Energy Resources Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Amgen Inc (AMGN):医療機器:M&Aディール及び事業提携情報
    Summary Amgen Inc (Amgen) is a biotechnology company that discovers, develops, manufactures and markets innovative human therapeutics to improve the lives of patients suffering from serious diseases. It develops novel medicines in six focused therapeutic areas including cardiovascular disease, oncol …
  • Siamab Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Siamab Therapeutics Inc (Siamab Therapeutics), formerly Sialix Inc, is a biopharmaceutical company that focuses on the development of novel medicines targeting cancer-specific carbohydrate antigens. Its ST1 program targets a tumor associated carbohydrate antigen present in solid tumors. Siam …
  • AstraZeneca KK:製薬・医療:M&Aディール及び事業提携情報
    Summary AstraZeneca KK (AstraZeneca) a subsidiary of AstraZeneca Plc is a drug company that provides prescription medicines. The company offers products such as akoreto, arimidex, iressa, inderal, casodex, crestor, and other tablets. It offers products for oncology, cardiovascular and metabolic dise …
  • Nostrum Oil & Gas PLC (NOG):石油・ガス:M&Aディール及び事業提携情報
    Summary Nostrum Oil & Gas PLC (Nostrum) is an independent oil and gas company. It produces, develops, and explores for oil and gas in the pre-Caspian Basin. The company produces crude oil, stabilized liquid condensate, LPG and dry gas. Nostrum has commercial hydrocarbon reserves in the Ardatovski, L …
  • Seadrill Limited (SDRL):石油・ガス:M&Aディール及び事業提携情報
    Summary Seadrill Limited (Seadrill) is an offshore drilling contractor. The company provides contract drilling, well services and engineering services to offshore exploration and production companies. Its fleet includes drillships, jack-up rigs, semi-submersibles, and tender rigs for operations in s …
  • Hawaiian Holdings, Inc.:企業の戦略・SWOT・財務分析
    Hawaiian Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary Hawaiian Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • The Save Mart Companies:企業の戦略・SWOT・財務情報
    The Save Mart Companies - Strategy, SWOT and Corporate Finance Report Summary The Save Mart Companies - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Warner Music Group Corp:企業の戦略的SWOT分析
    Warner Music Group Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Pathogenetix Inc-医療機器分野:企業M&A・提携分析
    Summary Pathogenetix Inc (Pathogenetix), formerly US Genomics, a subsidiary of Toxic Reports LLC is a medical device company that develops an automated system for bacterial strain typing from complex samples. The company develops products and applications based on its proprietary genome sequence sca …
  • Indeck Energy Services Inc:発電所・企業SWOT分析
    Indeck Energy Services Inc - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key em …
  • Applied Materials Inc (AMAT):企業の財務・戦略的SWOT分析
    Applied Materials Inc (AMAT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Shanghai Kehua Bio-engineering Co Ltd (002022):企業の財務・戦略的SWOT分析
    Shanghai Kehua Bio-engineering Co Ltd (002022) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key str …
  • Emlin Cosmetics :企業の戦略・SWOT・財務情報
    Emlin Cosmetics - Strategy, SWOT and Corporate Finance Report Summary Emlin Cosmetics - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Reliance Infrastructure Ltd (RELINFRA)-エネルギー分野:企業M&A・提携分析
    Summary Reliance Infrastructure Limited (RIL) is an utility company that generates, transmits, distributes, purchases and trades electricity in India. It provides electricity to power to residential, industrial, commercial and other consumers. The company offers value-added services in construction, …
  • EnPro Industries Inc (NPO):企業の財務・戦略的SWOT分析
    Summary EnPro Industries Inc (EnPro) is a diversified company that offers engineering solutions. The company designs, develops, manufactures and markets proprietary engineered industrial products. It provides commercial vehicle wheel-end components. EnPro offers sealing solutions for a wide range of …
  • KONE Corporation:企業のM&A・事業提携・投資動向
    KONE Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's KONE Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆